Stockholders' Equity

12 Months Ended

Oct. 31, 2025

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 8. Stockholders’ Equity

Analysis of Changes in Accumulated Other Comprehensive Income (Loss):

(In millions)	Foreign Currency Translation Adjustment		Derivative Instruments		Minimum Pension Liability		Total
Balance at October 31, 2022	$	(555.0)	$	94.4	$	(6.2)	$	(466.8)
Gross change in value	17.0		(9.4)		4.0		11.6
Tax effect	—		2.4		(1.0)		1.4
Balance at October 31, 2023	$	(538.0)	$	87.4	$	(3.2)	$	(453.8)
Gross change in value	$	76.3	$	(55.9)	$	(2.2)	$	18.2
Tax effect	—		13.4		0.5		13.9
Balance at October 31, 2024	$	(461.7)	$	44.9	$	(4.9)	$	(421.7)
Gross change in value	$	35.5	$	(35.5)	$	8.5	$	8.5
Tax effect	—		8.6		(1.9)		6.7
Balance at October 31, 2025	$	(426.2)	$	18.0	$	1.7	$	(406.5)

Share Repurchases

In September 2025, the authorization under the 2012 Share Repurchase Program was increased to $2.0 billion by the Company's Board of Directors. As of October 31, 2025, $966.4 million remains authorized for repurchase.

In fiscal 2025, the Company repurchased 4.1 million shares of its common stock for $290.1 million, at a weighted average price of $69.30 per share under the program. In fiscal 2024, there were no share repurchases under the program.

Dividends

In December 2023, the Company's Board of Directors decided to end the declaration of the semiannual dividend.

The Company did not pay dividends in fiscal 2025 and 2024.